Blueprint Medicines Corp·4

Jun 24, 4:19 PM ET

Tsai John 4

4 · Blueprint Medicines Corp · Filed Jun 24, 2025

Insider Transaction Report

Form 4
Period: 2025-06-18
Tsai John
Director
Transactions
  • Award

    Common Stock

    2025-06-18$128.12/sh+3,902$499,92412,644 total
Footnotes (1)
  • [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Documents

1 file
  • 4
    form4-06242025_080644.xmlPrimary